A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.

Summary

This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 27 July 2022

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 27 July 2022

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 27 July 2022 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 27 July 2022

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 27 July 2022

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 27 July 2022

  Open at official source

Sponsors

• Sen. Brown, Sherrod [D-OH] · D · Sponsor
• Tim Scott · R · Sponsor
• · ssfi00 · Standing

Related records

• related to → A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.